Live News EARNINGS H impact Jul 23, 2026, 10:46 AM UTC

Quest Diagnostics Raises FY2026 GAAP EPS Guidance from $9.58-$9.78 to $9.97-$10.17 vs $9.60 Est

Quest Diagnostics (NYSE: DGX ) raises FY2026 GAAP EPS guidance from $9.58-$9.78 to $9.97-$10.17 vs $9.60 analyst estimate..

DGX

SquawkNews Newsroom 1 updates Updated Jul 23, 2026, 10:47 AM UTC

Story updates

10:47:50 AM UTC

SquawkNews

Quest Diagnostics (NYSE: DGX ) raises FY2026 Adj EPS guidance from $10.63-$10.83 to $11.05-$11.25 vs $10.76 analyst estimate. Raises FY2026 sales outlook from $11.780 billion-$11.900 billion to $11.950 billion-$12.050 billion vs $11.851 billion estimate.

Quest Diagnostics (NYSE: DGX ) raises FY2026 Adj EPS guidance from $10.63-$10.83 to $11.05-$11.25 vs $10.76 analyst estimate.

Raises FY2026 sales outlook from $11.780 billion-$11.900 billion to $11.950 billion-$12.050 billion vs $11.851 billion estimate.